FIELD: synthesis of biologically active compounds.
SUBSTANCE: invention provides novel N6-substituted adenine-based heterocyclic compounds depicted by general formula I: , for which meanings of radicals are presented in description, and pharmaceutically acceptable salts thereof manifesting anticancer, mitotic, immunosuppressive, and antiaging activities for vegetable, animal, and human cells, and methods for preparation thereof. Included are also pharmaceutical compositions, cosmetic preparations, and growth regulators, which contain indicated derivatives as active components. Application of indicated derivatives for preparing therapeutical preparations, and cosmetic preparations are also described.
EFFECT: expanded synthetic possibilities in adenine series and increased choice of various biologically active agents.
10 cl, 10 dwg, 9 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
3-AMINOPYRROLIDONE DERIVATIVES | 2004 |
|
RU2395495C2 |
SUBSTITUTED GLUTARAMIDES, METHODS FOR THEIR PREPARING AND MEDICINAL AGENT BASED ON THEREOF | 2001 |
|
RU2278857C2 |
N-ACYL-N' -BENZYLALYLENEDIAMNO DERIVATIVES | 2004 |
|
RU2387636C2 |
THIENOPYRIMIDINES, METHOD OF THEIR SYNTHESIS (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1997 |
|
RU2199541C2 |
THIENOPYRIMIDINES WITH INHIBITORY EFFECT WITH RESPECT TO PHOSPHODIESTERASE V (PDE V), METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2197492C2 |
0 |
|
SU523634A3 | |
METHOD OF OBTAINING BENZYLAMINE DERIVATIVES OR SALTS THEREOF | 0 |
|
SU640657A3 |
0 |
|
SU521838A3 | |
0 |
|
SU521837A3 | |
0 |
|
SU528866A3 |
Authors
Dates
2007-07-10—Published
2002-08-01—Filed